Platelet uptake of GABA and glutamate in patients with bipolar disorder
Bipolar Disorders, 05/11/2012

1 Nidotherapy for people with schizophrenia Cochrane Reviews, April 11, 2013    Evidence Based Medicine    Clinical Article

2 Newly diagnosed depression is associated with increased beta-thromboglobulin levels and increased expression of platelet activation markers and platelet derived CD40-CD40L Journal of Psychiatric Research, April 12, 2013    Clinical Article

3 Use of asenapine in clinical practice for the management of bipolar mania Journal of Psychopharmacology, March 29, 2013    Review Article    Clinical Article

4 Risperidone, quetiapine, and olanzapine adjunctive treatments in major depression with psychotic features: a comparative study Full Text Neuropsychiatric Disease and Treatment, April 18, 2013    Free full text    Clinical Article

5 Buprenorphine augmentation in the treatment of refractory obsessive-compulsive disorder Therapeutic Advances in Psychopharmacology, March 1, 2013    Clinical Article

6 Efficacy and mood conversion rate during long-term fluoxetine v. lithium monotherapy in rapid- and non-rapid-cycling bipolar II disorder The British Journal of Psychiatry, April 3, 2013    Clinical Article

7 The association between low vitamin D and depressive disorders Full Text Molecular Psychiatry, April 10, 2013    Free full text    Clinical Article

8 A randomised, controlled trial of a dietary intervention for adults with major depression (the SMILES trial): study protocol Full Text BMC Psychiatry, April 19, 2013    Free full text    Clinical Article

9 An open trial of pregabalin as an acute and maintenance adjunctive treatment for outpatients with treatment resistant bipolar disorder Journal of Affective Disorders, March 22, 2013    Clinical Article

10 Add-on fluvoxamine treatment for schizophrenia: an updated meta-analysis of randomized controlled trials European Archives of Psychiatry and Clinical Neuroscience, April 22, 2013    Evidence Based Medicine    Clinical Article

11 Effectiveness of lurasidone vs. quetiapine XR for relapse prevention in schizophrenia: A 12-month, double-blind, noninferiority study Schizophrenia Research, April 16, 2013    Clinical Article

12 Rapid Effects of Deep Brain Stimulation for Treatment-Resistant Major Depression Biological Psychiatry, April 8, 2013    Clinical Article

13 Reboxetine Treatment for Autistic Spectrum Disorder of Pediatric Patients With Depressive and Inattentive/Hyperactive Symptoms: An Open-Label Trial Clinical Neuropharmacology, April 5, 2013    Clinical Article

14 Lower CSF Interleukin-6 predicts future depression in a population-based sample of older women followed for 17 years Brain, Behavior, and Immunity, April 19, 2013    Clinical Article
Exclusive Author Commentary

15 Efficacy of the novel antidepressant agomelatine for anxiety symptoms in major depression Human Psychopharmacology: Clinical and Experimental, March 28, 2013    Clinical Article

16 Cortisol Levels and Risk for Psychosis: Initial Findings from the North American Prodrome Longitudinal Study Biological Psychiatry, April 5, 2013    Clinical Article

17 Therapeutic effects of vitamin D as adjunctive therapy to fluoxetine in patients with major depressive disorder Australian and New Zealand Journal of Psychiatry, March 6, 2013    Clinical Article

18 Additional ECT increases BDNF-levels in patients suffering from major depressive disorders compared to patients treated with citalopram only Journal of Psychiatric Research, April 15, 2013    Clinical Article

19 Efficacy of vitamin C as an adjunct to fluoxetine therapy in pediatric major depressive disorder: a randomized, double-blind, placebo-controlled pilot study Full Text Nutrition Journal, March 14, 2013    Free full text    Clinical Article

20 Efficiacy of Melatonin in Chronic Tension Type Headache Patients and Effects on Anxiety and Depression Full Text Journal of Neurological Sciences (Turkish), April 1, 2013    Free full text    Clinical Article